Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease

Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiura, Hiroyuki, Sezaki, Nobuo, Ishikawa, Tatsunori, Kuroi, Taiga, Okamoto, Sachiyo, Nomura, Naho, Masunari, Taro, Nakasako, Yukio, Kiguchi, Toru, Tanimoto, Mitsune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010727/
https://www.ncbi.nlm.nih.gov/pubmed/35441018
http://dx.doi.org/10.1002/ccr3.5735
_version_ 1784687544645976064
author Sugiura, Hiroyuki
Sezaki, Nobuo
Ishikawa, Tatsunori
Kuroi, Taiga
Okamoto, Sachiyo
Nomura, Naho
Masunari, Taro
Nakasako, Yukio
Kiguchi, Toru
Tanimoto, Mitsune
author_facet Sugiura, Hiroyuki
Sezaki, Nobuo
Ishikawa, Tatsunori
Kuroi, Taiga
Okamoto, Sachiyo
Nomura, Naho
Masunari, Taro
Nakasako, Yukio
Kiguchi, Toru
Tanimoto, Mitsune
author_sort Sugiura, Hiroyuki
collection PubMed
description Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoclax.
format Online
Article
Text
id pubmed-9010727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90107272022-04-18 Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease Sugiura, Hiroyuki Sezaki, Nobuo Ishikawa, Tatsunori Kuroi, Taiga Okamoto, Sachiyo Nomura, Naho Masunari, Taro Nakasako, Yukio Kiguchi, Toru Tanimoto, Mitsune Clin Case Rep Case Reports Venetoclax is a promising new drug for relapsed or refractory chronic lymphocytic leukemia (CLL). However, venetoclax use had not been reported in severe chronic kidney disease (CKD) patients. We report the first case of relapsed CLL in a severe CKD patient that was successfully treated with venetoclax. John Wiley and Sons Inc. 2022-04-14 /pmc/articles/PMC9010727/ /pubmed/35441018 http://dx.doi.org/10.1002/ccr3.5735 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Sugiura, Hiroyuki
Sezaki, Nobuo
Ishikawa, Tatsunori
Kuroi, Taiga
Okamoto, Sachiyo
Nomura, Naho
Masunari, Taro
Nakasako, Yukio
Kiguchi, Toru
Tanimoto, Mitsune
Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title_full Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title_fullStr Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title_full_unstemmed Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title_short Successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
title_sort successful treatment of relapsed chronic lymphocytic leukemia with venetoclax in a patient with severe chronic kidney disease
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010727/
https://www.ncbi.nlm.nih.gov/pubmed/35441018
http://dx.doi.org/10.1002/ccr3.5735
work_keys_str_mv AT sugiurahiroyuki successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT sezakinobuo successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT ishikawatatsunori successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT kuroitaiga successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT okamotosachiyo successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT nomuranaho successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT masunaritaro successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT nakasakoyukio successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT kiguchitoru successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease
AT tanimotomitsune successfultreatmentofrelapsedchroniclymphocyticleukemiawithvenetoclaxinapatientwithseverechronickidneydisease

Ejemplares similares